e-learning
resources
Munich 2014
Sunday, 07.09.2014
Exposure measurement and biological effects of pollutants at work, outdoor and at home
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Usefulness of myeloperoxidase as a biomarker for nanoparticles' toxicity
T. Tomonaga, H. Izumi, Y. Yoshiura, T. Myojo, T. Oyabu, B. W. Lee, T. Okada, Y. Morimoto (Fukuoka, Japan)
Source:
International Congress 2014 – Exposure measurement and biological effects of pollutants at work, outdoor and at home
Session:
Exposure measurement and biological effects of pollutants at work, outdoor and at home
Session type:
Poster Discussion
Number:
1492
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Tomonaga, H. Izumi, Y. Yoshiura, T. Myojo, T. Oyabu, B. W. Lee, T. Okada, Y. Morimoto (Fukuoka, Japan). Usefulness of myeloperoxidase as a biomarker for nanoparticles' toxicity. Eur Respir J 2014; 44: Suppl. 58, 1492
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
The impact of anti-IgE treatment on the airway microbiome in asthma.
Occupational and drug-induced ILDs
Related content which might interest you:
Hard metal lung disease – Role of bronchoalveolar lavage in the diagnosis
Source: International Congress 2014 – Occupational respiratory diseases: from drug-induced disease to COPD induced by the uranium industry
Year: 2014
Look closer to welders' lung
Source: International Congress 2014 – Occupational respiratory diseases
Year: 2014
Significance of alveolar lavage in assessing the aggressivity of different occupational exposures
Source: International Congress 2015 – Occupational and environmental cohort investigations and population studies
Year: 2015
Oxidative imbalance in biological fluids of heavy metals-exposed workers
Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Year: 2016
Comparison of eicosanoids in sputum, bronchoalveolar lavage and exhaled breath condensate
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Utility of bronchoalveolar lavage in the determination of lung asbestos burden in Barcelona, Spain
Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Year: 2013
Distribution of surfactant proteins in proximal and distal airways
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Diagnostic value of pneumocystis-PCR in bronchoalveolar lavage in a clinical setting
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Bronchopulmonary system changes in the employees of nuclear industry
Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Year: 2016
Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Utility of bronchoalveolar lavage in vasculitis patients
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Inflammatory response to fine particulate air pollution exposure: Neutrophil versus monocyte
Source: International Congress 2014 – Exposure measurement and biological effects of pollutants at work, outdoor and at home
Year: 2014
Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Elevated Tryptase concentration In bronchoalveolar lavage fluid from patients with chronic eosinophilic pneumonia
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Potential lung cancer biomarkers from bronchoalveolar lavage fluid using metabolomics approaches
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
The value of bronchoalveolar lavage in the diagnosis and management of small airway disease
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Assessment of neutrophil serine proteinases activity in bronchoalveolar lavage fluids from patients with interstitial lung diseases using innovative intramolecular quenched substrates
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept